Anaptysbio Stock News & Updates

[WKN: A2AJ8C | Symbol: ANAB]
Anaptysbio

AnaptysBio as a Pure Royalty Manager: Jemperli Dynamics and the Overlooked Imsidolimab Potential Justify $95 Price Target

Analysts' Top 5 Price Targets of December 19, 2025

Omada Health [US68170A1088] Morgan Stanley assigns the stock a top recommendation - price target of...

TOP-5 Price Targets of Analysts on 13.10.25

Applied Digital [US0381692070] Roth MKM reaffirms Buy rating and raises price target from $43 to...

  • ‹
  • 1
  • ›